Skip to Main Content

Paper Details

A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int J Cancer
5
2023
C1QA, CD146, CD29, CD44, CD81, EVs, Extracellular vesicles, glioblastoma, glioblastoma tumor, histone H3, patients, serum EVs, serum-derived EVs, tumor
Author NameAffiliation
Theophilos TzaridisUniversity Hospital, University of Bonn
Theophilos TzaridisSanford Burnham Prebys Medical Discovery Institute
Theophilos TzaridisDivision of Clinical Neurooncology, University of Bonn
Andreas BunessInstitute for Medical Biometry, Institute for Genomic Statistics and Bioinformatics, University of Bonn
Robert J Wechsler-ReyaSanford Burnham Prebys Medical Discovery Institute
Robert J Wechsler-ReyaSanford Burnham Prebys Medical Discovery Institute
Bj??rn SchefflerDKFZ-Division Translational Neurooncology at the West German Cancer Center and German Cancer Consortium, University Hospital Essen
Martin GlasDivision of Clinical Neurooncology, Department of Neurology and West German Cancer Center, University Hospital Essen
  • 1 - 8

Datasets